Jane Street’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Jane Street’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-38,100	Closed	-$92K	–	10673
2022 Q2	$92K	Sell	38,100 -74,300	-66%	-$195K	﹤0.01%	8684
2022 Q1	$463K	Buy	112,400 +42,600	+61%	+$226K	﹤0.01%	7632
2021 Q4	$898K	Sell	69,800 -102,100	-59%	-$1.13M	﹤0.01%	6120
2021 Q3	$1.86M	Buy	+171,900	New	+$1.56M	﹤0.01%	4627

Other funds holding GRTS

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Jane Street's GRTS Position: Q4 2024 in Review

Jane Street sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 138,189 shares — an estimated $80.1K sold.

Jane Street first reported a position in GRTS in Q3 2020 and held it in 14 quarters. The position peaked at $1.11M in Q1 2023. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

Jane Street reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Jane Street sold 138,189 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $80.1K.
Jane Street first reported a position in Gritstone bio, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
Jane Street's Gritstone bio, Inc. Common Stock position peaked at $1.11M in Q1 2023.
6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.